Skip to main content

Table 2 STOPGAP intraperitoneal chemotherapy regimen

From: Phase II clinical trial of sequential treatment with systemic chemotherapy and intraperitoneal paclitaxel for gastric and gastroesophageal junction peritoneal carcinomatosis - STOPGAP trial

Agent

Dose

Route

Schedule

Leucovorin

20 mg/m2

IV

Days 1 and 8

5-FU

400 mg/m2

IV

Days 1 and 8

Paclitaxel

50 mg/m2

IV

Days 1and 8

Paclitaxel

40 mg/m2

IP

Days 1and 8

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us